---
title: 'The value of subcutaneous xenografts for individualised radiotherapy in HNSCC:
  robust gene signature correlates with radiotherapy outcome in patients and xenografts'
date: '2023-12-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38109944/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231219170639&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSION: Genetic prognosticators of outcome for patients after PORT-C
  and subcutaneous xenografts after primary clinically relevant irradiation show similarity.
  The identified robust 2-gene signature may help to guide patient stratification,
  after prospective validation. Thus, xenografts remain a valuable resource for translational
  research towards the development of individualized ...'
disable_comments: true
---
CONCLUSION: Genetic prognosticators of outcome for patients after PORT-C and subcutaneous xenografts after primary clinically relevant irradiation show similarity. The identified robust 2-gene signature may help to guide patient stratification, after prospective validation. Thus, xenografts remain a valuable resource for translational research towards the development of individualized ...